Transforming growth factor β1 induces osteogenic differentiation of murine bone marrow stromal cells

Tissue Engineering - Part A

Volumn 16, Issue 2, 2010, Pages 725-733

  Zhao, Longmei ^a   Jiang, Shu ^a   Hantash, Basil M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVITY; PEPTIDES; PHOSPHATASES; POLYMERASE CHAIN REACTION; TRANSCRIPTION;

ADIPOGENIC; ALKALINE PHOSPHATASE ACTIVITY; BINDING MOTIF; BONE INJURY; BONE MARROW STROMAL CELLS; BONE MORPHOGENIC PROTEIN; BONE REPAIR; FRACTURE HEALING; GENE TRANSCRIPTIONS; IMMUNOHISTOCHEMICAL STAINING; IN-VITRO; MRNA LEVEL; OSTEOBLAST DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; PERIPHERAL BLOOD; PHYSIOLOGICAL GROWTH; POST-FRACTURE; PROTEIN LEVEL; REVERSE TRANSCRIPTASE- POLYMERASE CHAIN REACTION; TERMINAL DIFFERENTIATION; TISSUE TYPES; TRANSCRIPTIONAL CO-ACTIVATORS; TRANSFORMING GROWTH FACTORS; UP-REGULATION;

BONE;

MURINAE;

ALKALINE PHOSPHATASE; EPIDERMAL GROWTH FACTOR; MESSENGER RNA; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ADIPOGENESIS; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BONE DEVELOPMENT; BONE MARROW CELL; CELL DIFFERENTIATION; CELL LINEAGE; CELL SEPARATION; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; FEMALE; FIBROBLAST; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; MOUSE; STROMA CELL;

ADIPOGENESIS; ALKALINE PHOSPHATASE; ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINEAGE; CELL SEPARATION; EPIDERMAL GROWTH FACTOR; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; MALE; MICE; MICE, INBRED BALB C; OSTEOGENESIS; RNA, MESSENGER; SMAD PROTEINS; STROMAL CELLS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77049089562     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2009.0495     Document Type: Conference Paper

References (36)

1. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., and Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
2. Deans, R.J., and Moseley, A.B. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 28, 875, 2000.
3. Pereira, R.F., Halford, K.W., O'Hara, M.D., Leeper, D.B., Sokolov, B.P., Pollard, M.D., Bagasra, O., and Prockop, D.J. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci USA 92, 4857, 1995.
4. Quarto, R., Mastrogiacomo, M., Cancedda, R., Kutepov, S.M., Mukhachev, V., Lavroukov, A., Kon, E., and Marcacci, M. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 344, 385, 2001.
5. Tseng, S.S., Lee, M.A., and Reddi, A.H. Nonunions and the potential of stem cells in fracture-healing. J Bone Joint Surg Am 90 Suppl 1, 92, 2008.
6. Zimmermann, G., Henle, P., Kusswetter, M., Moghaddam, A., Wentzensen, A., Richter, W., and Weiss, S. TGF-beta1 as a marker of delayed fracture healing. Bone 36, 779, 2005.
7. Devescovi, V., Leonardi, E., Ciapetti, G., and Cenni, E. Growth factors in bone repair. Chir Organi Mov 92, 161, 2008.
8. Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., Bronson, R.T., Gao, Y.H., Inada, M., Sato, M., Okamoto, R., Kitamura, Y., Yoshiki, S., and Kishimoto, T. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89, 755, 1997.
9. Otto, F., Thornell, A.P., Crompton, T., Denzel, A., Gilmour, K.C., Rosewell, I.R., Stamp, G.W., Beddington, R.S., Mundlos, S., Olsen, B.R., Selby, P.B., and Owen, M.J. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89, 765, 1997.
10. Hong, J.H., Hwang, E.S., McManus, M.T., Amsterdam, A., Tian, Y., Kalmukova, R., Mueller, E., Benjamin, T., Spiegel-man, B.M., Sharp, P.A., Hopkins, N., and Yaffe, M.B. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 309, 1074, 2005.
11. Hong, J.H., and Yaffe, M.B. TAZ: a beta-catenin-like molecule that regulates mesenchymal stem cell differentiation. Cell Cycle 5, 176, 2006.
12. Peister, A., Mellad, J.A., Larson, B.L., Hall, B.M., Gibson, L.F., and Prockop, D.J. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 103, 1662, 2004.
13. Salasznyk, R.M., Klees, R.F., Williams, W.A., Boskey, A., and Plopper, G.E. Focal adhesion kinase signaling pathways regulate the osteogenic differentiation of human mesenchy-mal stem cells. Exp Cell Res 313, 22, 2007.
14. Hata, K., Nishimura, R., Ueda, M., Ikeda, F., Matsubara, T., Ichida, F., Hisada, K., Nokubi, T., Yamaguchi, A., and Yo-neda, T. A CCAAT=enhancer binding protein beta isoform, liver-enriched inhibitory protein, regulates commitment of osteoblasts and adipocytes. Mol Cell Biol 25, 1971, 2005.
15. Holmes, C., and Stanford, W.L. Concise review: stem cell antigen-1: expression, function, and enigma. Stem Cells 25, 1339, 2007.
16. Muraglia, A., Cancedda, R., and Quarto, R. Clonal mesen-chymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 113 (Pt 7), 1161, 2000.
17. Bruder, S.P., Jaiswal, N., and Haynesworth, S.E. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive sub-cultivation and following cryopreservation. J Cell Biochem 64, 278, 1997.
18. Lolicato, F., Marino, R., Paronetto, M.P., Pellegrini, M., Dolci, S., Geremia, R., and Grimaldi, P. Potential role of Nanos3 in maintaining the undifferentiated spermatogonia population. Dev Biol 313, 725, 2008.
19. Lin, T., Islam, O., and Heese, K. ABC transporters, neural stem cells and neurogenesis-a different perspective. Cell Res 16, 857, 2006.
20. Xu, R.H., Peck, R.M., Li, D.S., Feng, X., Ludwig, T., and Thomson, J.A. Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat Methods 2, 185, 2005.
21. Korkola, J.E., Houldsworth, J., Chadalavada, R.S., Olshen, A.B., Dobrzynski, D., Reuter, V.E., Bosl, G.J., and Chaganti, R.S. Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors. Cancer Res 66, 820, 2006.
22. Israeli, D., Ziaei, S., Gonin, P., and Garcia, L. A proposal for the physiological significance of mdr1 and Bcrp1=Abcg2 gene expression in normal tissue regeneration and after cancer therapy. J Theor Biol 232, 41, 2005.
23. Elabd, C., Chiellini, C., Massoudi, A., Cochet, O., Zaragosi, L.E., Trojani, C., Michiels, J.F., Weiss, P., Carle, G., Rochet, N., Dechesne, C.A., Ailhaud, G., Dani, C., and Amri, E.Z. Human adipose tissue-derived multipotent stem cells differentiate in vitro and in vivo into osteocyte-like cells. Bio-chem Biophys Res Commun 361, 342, 2007.
24. Platt, M.O., Roman, A.J., Wells, A., Lauffenburger, D.A., and Griffith, L.G. Sustained epidermal growth factor receptor levels and activation by tethered ligand binding enhances osteogenic differentiation of multi-potent marrow stromal cells. J Cell Physiol 221, 306, 2009.
25. Tsialogiannis, E., Polyzois, I., Oak Tang, Q., Pavlou, G., Tsiridis, E., and Heliotis, M. Targeting bone morphogenetic protein antagonists: in vitro and in vivo evidence of their role in bone metabolism. Expert Opin Ther Targets 13, 123, 2009.
26. Murakami, M., Tominaga, J., Makita, R., Uchijima, Y., Kur-ihara, Y., Nakagawa, O., Asano, T., and Kurihara, H. Tran-scriptional activity of Pax3 is co-activated by TAZ. Biochem Biophys Res Commun 339, 533, 2006.
27. Cui, C.B., Cooper, L.F., Yang, X., Karsenty, G., and Aukhil, I. Transcriptional coactivation of bone-specific transcription factor Cbfa1 by TAZ. Mol Cell Biol 23, 1004, 2003.
28. Mahoney, W.M., Jr., Hong, J.H., Yaffe, M.B., and Farrance, I.K. The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members. Biochem J 388, 217, 2005.
29. Park, K.S., Whitsett, J.A., Di Palma, T., Hong, J.H., Yaffe, M.B., and Zannini, M. TAZ interacts with TTF-1 and regulates expression of surfactant protein-C. J Biol Chem 279, 17384, 2004.
30. Murakami, M., Nakagawa, M., Olson, E.N., and Nakagawa, O. A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome. Proc Natl Acad Sci USA 102, 18034, 2005.
31. Wrighton, K.H., Dai, F., and Feng, X.H. A new kid on the TGFbeta block: TAZ controls Smad nucleocytoplasmic shuttling. Dev Cell 15, 8, 2008.
32. Varelas, X., Sakuma, R., Samavarchi-Tehrani, P., Peerani, R., Rao, B.M., Dembowy, J., Yaffe, M.B., Zandstra, P.W., and Wrana, J.L. TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. Nat Cell Biol 10, 837, 2008.
33. Han, F., Adams, C.S., Tao, Z., Williams, C.J., Zaka, R., Tuan, R.S., Norton, P.A., and Hickok, N.J. Transforming growth factor-beta1 (TGF-beta1) regulates ATDC5 chondrogenic differentiation and fibronectin isoform expression. J Cell Biochem 95, 750, 2005.
34. Mehlhorn, A.T., Niemeyer, P., Kaiser, S., Finkenzeller, G., Stark, G.B., Sudkamp, N.P., and Schmal, H. Differential expression pattern of extracellular matrix molecules during chondrogenesis of mesenchymal stem cells from bone marrow and adipose tissue. Tissue Eng 12, 2853, 2006.
35. Centrella, M., Horowitz, M.C., Wozney, J.M., and McCarthy, T.L. Transforming growth factor-beta gene family members and bone. Endocr Rev 15, 27, 1994.
36. Janssens, K., ten Dijke, P., Janssens, S., and Van Hul, W. Transforming growth factor-beta1 to the bone. Endocr Rev 26, 743, 2005.